1. Home
  2. LUNG vs VRA Comparison

LUNG vs VRA Comparison

Compare LUNG & VRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • VRA
  • Stock Information
  • Founded
  • LUNG 1995
  • VRA 1982
  • Country
  • LUNG United States
  • VRA United States
  • Employees
  • LUNG N/A
  • VRA N/A
  • Industry
  • LUNG Industrial Specialties
  • VRA Apparel
  • Sector
  • LUNG Health Care
  • VRA Consumer Discretionary
  • Exchange
  • LUNG Nasdaq
  • VRA Nasdaq
  • Market Cap
  • LUNG 65.6M
  • VRA 60.6M
  • IPO Year
  • LUNG 2020
  • VRA 2010
  • Fundamental
  • Price
  • LUNG $1.55
  • VRA $2.05
  • Analyst Decision
  • LUNG Buy
  • VRA Buy
  • Analyst Count
  • LUNG 7
  • VRA 3
  • Target Price
  • LUNG $7.66
  • VRA $3.05
  • AVG Volume (30 Days)
  • LUNG 480.4K
  • VRA 236.7K
  • Earning Date
  • LUNG 10-29-2025
  • VRA 09-11-2025
  • Dividend Yield
  • LUNG N/A
  • VRA N/A
  • EPS Growth
  • LUNG N/A
  • VRA N/A
  • EPS
  • LUNG N/A
  • VRA N/A
  • Revenue
  • LUNG $90,549,000.00
  • VRA $332,526,000.00
  • Revenue This Year
  • LUNG $10.30
  • VRA N/A
  • Revenue Next Year
  • LUNG $14.72
  • VRA $3.80
  • P/E Ratio
  • LUNG N/A
  • VRA N/A
  • Revenue Growth
  • LUNG 18.24
  • VRA N/A
  • 52 Week Low
  • LUNG $1.47
  • VRA $1.71
  • 52 Week High
  • LUNG $9.37
  • VRA $5.99
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 37.40
  • VRA 46.44
  • Support Level
  • LUNG $1.60
  • VRA $1.94
  • Resistance Level
  • LUNG $1.76
  • VRA $2.49
  • Average True Range (ATR)
  • LUNG 0.13
  • VRA 0.16
  • MACD
  • LUNG 0.02
  • VRA -0.01
  • Stochastic Oscillator
  • LUNG 2.86
  • VRA 20.00

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

Share on Social Networks: